Studying Development of Disease Through Temporally Controlled Gene Expression in the Salivary Glanda
- 1 April 1998
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 842 (1) , 181-187
- https://doi.org/10.1111/j.1749-6632.1998.tb09646.x
Abstract
Multistep tumorigenesis proceeds through activation of oncogenes and inactivation of tumor suppressor genes. Initiating oncoproteins induce secondary changes that maintain transformation in the absence of original stimuli. Time-dependent reversal of SV40 T antigen (TAg)-induced hyperplasia was studied using temporally controlled gene expression. Targeting TAg expression to the submandibular salivary gland of transgenic mice produces focal hyperplasias at age two weeks, which extend through large areas of the gland by four months. At twelve months, fibrosis and tumor foci accompany hyperplasia. Hyperplasia reverses when TAg expression in discontinued at four months but not at seven months. Secondary changes that maintain transformation appear to be time dependent. The system can be used to identify genetic events resulting in phenotypic reversal at four months and to expose factors preventing its occurrence at seven months. Expression of other proteins can be targeted to the salivary gland, and temporally controlled gene deletions can also be made using this system.Keywords
This publication has 21 references indexed in Scilit:
- Control of Memory Formation Through Regulated Expression of a CaMKII TransgeneScience, 1996
- Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoterNucleic Acids Research, 1996
- Conditional Transgene Expression in the HeartCirculation Research, 1996
- Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Efficient control of gene expression by single step integration of the tetracycline system in transgenic miceNature Biotechnology, 1996
- Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV‐LTR and the tetracycline responsive systemJournal of Cellular Biochemistry, 1995
- Human COL2A1-directed SV40 T antigen expression in transgenic and chimeric mice results in abnormal skeletal development.The Journal of cell biology, 1995
- Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.Proceedings of the National Academy of Sciences, 1994
- p53-Dependent apoptosis suppresses tumor growth and progression in vivoCell, 1994
- Hepatocarcinogenesis in Transgenic Mice Carrying Albumin‐promoted SV40 T Antigen GeneJapanese Journal of Cancer Research, 1991